Bristol-Myers Shares Sputter After Setback for Top Cancer Drug

(Bloomberg) -- Bristol-Myers Squibb Co. suffered another setback for its biggest-selling cancer drug on Wednesday, sending shares of the drugmaker lower in late trading.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.